ORA Lab Closings Cancelled But Reorganization Not Off The Table – Staffers
This article was originally published in The Tan Sheet
Executive Summary
FDA's head of regulatory affairs' Aug. 17 message to staff about cancelling plans to close seven field labs did not mark the end of the agency's ORA reorganization work, staff members say
You may also be interested in...
E&C investigation
The House Energy and Commerce Subcommittee on Oversight and Investigations announces Aug. 24 it is investigating FDA's plan to outsource jobs. Energy and Commerce Chairman John Dingell, D-Mich., and Subcommittee Chair Bart Stupak, D-Mich., say in a release they were "incredulous" when they learned of FDA's plan to outsource 332 positions. The news comes one week after Dingell and Stupak commended the Office of Regulatory Affairs' plan to shut down seven labs (1"The Tan Sheet" Aug. 27, 2007, p. 6). The congressmen are asking for a list of the positions as well as descriptions of job responsibilities, records reflecting the plans, budget analyses and more by Sept. 7...
FDA Reconsiders ORA Reorganization As Questions From Congress Continue
FDA's Aug. 1 decision to temporarily suspend plans to close seven of its 13 field laboratories as part of its Office of Regulatory Affairs reorganization follows repeated protests and inquiries from Capitol Hill, including a July 31 letter from two of the proposal's chief critics
Appropriators Boost FDA Budget For Food Safety While Opposing Lab Closings
House and Senate appropriators make it known in reports on FDA's fiscal 2008 appropriation that they question the agency's plan to close more than half of its field labs, with the House bill specifically banning funding for the reorganization